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Background: The situation for older persons with mental disorders other than dementia disorders has scarcely
been studied. The older population is increasing worldwide and along with this increase the prevalence of mental
disorders will also rise. The treatment of older persons with mental disorders entails complex challenges, with drugs
constituting the major medical treatment. Knowledge of geriatric psychiatry is essential for providing older persons
with appropriate treatment and care. This study aimed to evaluate the prescription of drugs for mental disorders to
older persons (≥65) in Sweden, focused on the medical specialties of the prescribing physicians.
Methods: Data concerning drug treatment for older persons from 2006 to 2008 was gathered from the Swedish
Prescribed Drug Register. Mental disorders, defined as affective, psychotic and anxiety disorders (ICD-10 F20-42)
were evaluated in order to identify associated drugs. Included was a total of 188 024 older individuals, who
collectively filled 2 013 079 prescriptions for the treatment of mental disorders. Descriptive analyses were
performed, including frequency distribution and 95% CI. The competence of the prescribers was analyzed by
subdividing them into five groups: geriatricians, psychiatrists, general practitioners (GPs), other specialists, and
physicians without specialist education.
Results: GPs represented the main prescribers, whereas geriatricians and psychiatrists rarely prescribed drugs to
older persons. Benzodiazepines and tricyclic antidepressants were the most commonly prescribed drugs. Women
were prescribed drugs from geriatricians and psychiatrists to a greater extent than men.
Conclusions: This study examined the prescription of psychotropic drugs to older persons. Physicians specialized in
older persons’ disorders and mental health were rarely the prescribers of these drugs. Contrary to clinical guidelines,
benzodiazepines and tricyclic antidepressants were commonly prescribed to older persons, emphasizing the need
for continuous examination of pharmaceutical treatment for older persons. The results indicate a future need of
more specialists in geriatrics and psychiatry.
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The world is facing a demographical shift in which the
older population will increase. It is thus fair to assume
that the prevalence of disorders that are common among
older persons will also increase. Studies have shown that
mental disorders are prevalent among the old [1-3], even
when dementia disorders are excluded [4,5]. The treat-
ment of mental disorders (i.e. affective, psychotic and
anxiety disorders) in older persons is a complex task and
can be affected by a variety of factors, including pharma-
cokinetic and pharmacodynamic changes related to age,
influences of concurrent disorders and possible adverse
drug reactions. Although the risk of adverse drug reac-
tions increases with age, drug treatment is common
among older persons, both nationally [6] and inter-
nationally [7]. As older persons are often treated for sev-
eral conditions besides mental disorders, the possibility
for unwanted drug interactions is increased in this age
group. Indeed, several studies have reported that older
persons are subjected to polypharmacy and inappropri-
ate drug use [8-10], and that many hospitalizations occur
due to drug related problems [11].
The treatment of mental disorders often involves several
different physicians, raising questions about who ultim-
ately carries the responsibility for the adequacy and quality
of the combined pharmaceutical regime. In addition, the
time allocated to mental health issues during consultations
with physicians is generally low [12] and the combination
of several prescribers commonly entails more drugs and
lower overall quality of care [13]. At present, very little
time (at most two weeks) is allocated to the field of geria-
trics during the training to become a licensed physician in
Sweden [14]. Specialists in geriatrics and psychiatry repre-
sent approximately 2% and 6%, respectively, of the
licensed physicians in Sweden, while physicians with spe-
cialist education in general medicine (general practi-
tioners, GPs) represent 18% [15]. Hence, there is an
obvious lack of physicians with specialized skills in treat-
ing older persons with mental disorders.
GPs providing care for older persons have reported
feeling insecure when required to surpass their own
competence, as well as a lack of communication with
other physicians and specialists [16]; these factors can
negatively impact the treatment and care given to older
persons with mental disorders. Studies have demon-
strated that treatment by geriatric teams reduces mortal-
ity [17,18] and increases the possibility for older persons
to remain at home [19,20]. Although the particular
knowledge that geriatricians acquire is vital in providing
older persons with adequate treatment and care, health
care personnel tend to prefer interdisciplinary teams
comprising different medical specialties when treating
and caring for older persons with or without mental dis-
orders [21,22]. Psychiatrists in particular contributeimportant knowledge on mental health and, as they gen-
erally hold more positive professional attitudes towards
people with mental disorders such as schizophrenia [23],
they would preferably be included in such a team.
The current situation for older persons with mental dis-
orders has scarcely been studied and questions have been
raised as to whether or not older persons with extensive
needs receive adequate care and treatment. In order to fa-
cilitate the improvement of treatment and to reduce pos-
sible adverse drug reactions among older persons with
mental disorders, it is important to evaluate the amounts
and types of drugs older persons are being prescribed and
which medical specialties their prescribers hold.
Aim
This study aimed to evaluate the prescription of drugs
for mental disorders to older persons (≥65 years) in Swe-
den during the three-year period from 2006 to 2008, fo-
cusing on the medical specialties among the prescribing




All persons in Sweden aged 65 years and older were
included in this analysis if they had received one or
more registered prescriptions for drugs for mental disor-
ders included in the International Classification of Dis-
eases, version 10 (ICD-10) F20-F42 [24] during 2006,
2007 or 2008. A total of 188 024 individuals, who to-
gether received 2 013 079 dispensed drugs for mental
disorders during the years 2006, 2007 and 2008, were
included in the study.
Data measurement
The Swedish Prescribed Drug Register (SPDR) from the
Swedish National Board of Health and Welfare was the
source for the data included in the analysis. All personal in-
formation was replaced with serial numbers. The variables
included were age (65 years and older), sex, ATC codes
(level 5; chemical substance), prescribing and dispensing
dates, as well as the specialist codes for the prescribers.
Data collection and analysis
The SPDR was used to explore the prescription of drugs
for mental disorders to older persons. Complete informa-
tion about the drugs dispensed at national pharmacies is
included in the register. As social security numbers were
introduced to the register in 2005, the analyses were car-
ried out using data from 2006 to 2008. Older persons re-
ceiving prescriptions for drugs indicated or recommended
in the Swedish Medicines Information portal [25-28] for
use in psychotic (F20-29, ICD-10), affective (F30-39, ICD-
10) and anxiety (F41-42, ICD-10) disorders, Chapter V,
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ical Therapeutic Chemical Classification (ATC) codes,
level 5, were subsequently applied (see Table 1). Drugs
intended for use in dementia disorders (ICD-10: F00-03;
ATC: N06DA02-04, N06DX01) or recommended as first-
hand choice in dementia disorders (ATC: N05AA-AX,
N05CF-CM, N06AB, N06DA-DX) have been excluded to
avoid analyzing persons with diffuse symptoms that could
be classified as either mental disorders or dementia disor-
ders. All prescriptions filled and dispensed during the
three-year period were included in the analysis.
The Swedish system for attaining a specialist degree as a
physician includes at least five years of full-time
specialization education following undergraduate studies
and involves working under supervision and attending
complementary education. During the years 2006, 2007Table 1 Evaluated disorders from International
Classification of Diseases version 10 (ICD-10), Chapter V
Mental and behavioral disorders: F20-29 (schizophrenia,
schizotypal and delusional disorders), F30-39 (affective
disorders), F41 (other anxiety disorders) and F42
(obsessive-compulsive disorders); the applied ATC codes
level 5 and the corresponding chemical substances
included in the study
ATC level 5 Chemical substance F20-29 F30-39 F41 F42
N03AE01 Clonazepam X
N03AF01 Carbamazepin X




N05BA01 Diazepam X X X
N05BA04 Oxazepam X X X
N05BA06 Lorazepam X X X
N05BA12 Alprazolam X X X
N05BE01 Buspirone X X
N06AA04 Clomipramine X X X
N06AA06 Trimipramine X X
N06AA09 Amitriptyline X X
N06AA10 Nortriptyline X X







N06AX18 Reboxetin X X
N06AX21 Duloxetine X
N06BA07 Modafinil Xand 2008 there were a total of 62 different specialties pos-
sible for physicians, and a given physician may hold sev-
eral different specialties. In the data analyses, the specialist
categories were divided into four groups: general practi-
tioners (GPs), geriatricians, psychiatrists (including spe-
cialist education in forensic psychiatry as well as children
and young peoples’ psychiatry) and “other specialists”
comprising all other specialists. Licensed physicians with
no specialist education were analyzed separately. Descrip-
tive univariate analyses with frequency distribution and
95% CI were carried out using IBM SPSS Statistics 19.0
for Windows (SPSS Inc. an IBM company, 1989–2010).
The regional ethics board in Uppsala, Sweden critically
and ethically revised and approved this study to be com-
pliant with the Helsinki Declaration [29] (Reference
number 2008/345/2).
Results
On average, 7% of the older population was prescribed
drugs for mental disorders during the years 2006, 2007
and 2008 (see Table 2), with more than one-half million
prescriptions dispensed to the older population at na-
tional pharmacies each year. Women constituted two-
thirds and men one-third of the older population receiv-
ing these drugs.
Drugs corresponding to 25 different ATC codes, level
5, were dispensed to older persons (≥65) in Sweden from
2006 to 2008, all of which were included in the analysis
(see Table 3). Each ATC code corresponds to one spe-
cific chemical substance and may have several brand
names. The most commonly prescribed and dispensed
chemical substances during each of the three years were
the benzodiazepines oxazepam and diazepam (anxioly-
tics), as well as the non-selective monoamine reuptake
inhibitor amitriptyline (antidepressant). The amount and
frequency of prescriptions for many of these chemical
substances changed over the course of the three years: a
decrease was seen in prescriptions for 48% of the sub-
stances and an increase for 24%.
On average, during the period from 2006 to 2008,
two-thirds (65%) of the prescribing physicians were GPs
(see Figure 1), whereas approximately 4% were geriatri-
cians and 3% psychiatrists. Approximately 14% of the
prescribers were physicians with specialist education
other than the aforementioned, the majority of whom
were specialists in internal medicine, cardiology or neur-
ology. Physicians without any specialist education corre-
sponded to 14% of the prescribers. The tendency of GPs
and geriatricians to hand out prescriptions increased
with the age of the patient, while the amount of pre-
scriptions from psychiatrists, other specialists, and phy-
sicians with no specialist education decreased with age.
Among the dispensed substances, the most commonly
prescribed were two benzodiazepine derivatives and one
Table 2 Characteristics of the study population: number of persons in the older population and number of persons (n)
receiving dispensed drugs for mental disorders (MD) (ICD-10: F20-F42), mean age with standard deviation (SD),
percentage men and women in the study population, and total number of dispensed drugs for mental disorders
2006 2007 2008
Older population, total (n) 1 581 437 1 608 413 1 645 081
Persons receiving drugs for MD (n) 104 441 106 665 108 306
Mean age (years) (SD) 77.8 (7.8) 77.8 (7.8) 77.7 (7.9)
Men/Women (%) 35/65 35/65 36/64
Total number of dispensed drugs for MD 639 841 671 071 702 167
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During 2006 to 2008, an average of 39% of the study
population was prescribed the anxiolytic oxazepam, while
approximately 18% was prescribed diazepam. The anti-
depressant amitriptyline was prescribed to 11% of the
study population yearly, from 2006 to 2008. GPs repre-
sented the category of physicians that most commonly
prescribed these top three ATC codes. While men andTable 3 Frequency of ATC codes prescribed to the study popu
ATC Chem. Sub. ICD 2006
n % 95% CI
N03AE01 Clonazepam 42 1015 0.97 0.91-1.03
N03AF01 Carbamazepin 31 7917 7.58 7.42-7.74
N03AG01 Valproic acid 31 2220 2.13 2.04-2.21
N03AX09 Lamotrigine 31 1259 1.21 1.14-1.27
N03AX16 Pregabalin 41 2641 2.53 2.43-2.62
N04BC05 Pramipexole 30-39 6188 5.92 5.78-6.07
N05BA01 Diazepam 20-39, 41 20075 19.22 18.98-19
N05BA04 Oxazepam 20-39, 41 41521 39.76 39.46-40
N05BA06 Lorazepam 20-39, 41 1175 1.13 1.06-1.19
N05BA12 Alprazolam 20-39, 41 3992 3.82 3.71-3.94
N05BE01 Buspirone 30-39, 41 473 0.45 0.41-0.49
N06AA04 Clomipramine 20-29, 41-42 2841 2.72 2.62-2.82
N06AA06 Trimipramine 20-39 342 0.33 0.29-0.36
N06AA09 Amitriptyline 20-39 11914 11.41 11.21-11
N06AA10 Nortriptyline 20-39 381 0.36 0.33-0.40
N06AA21 Maprotiline 20-39 413 0.40 0.36-0.43
N06AG02 Moclobemide 30-39 186 0.18 0.15-0.20
N06AX02 Tryptophan 30-39 36 0.03 0.02-0.05
N06AX03 Mianserin 30-39 1575 1.51 1.43-1.58
N06AX11 Mirtazapine 30-39 9296 8.90 8.73-9.07
N06AX12 Bupropion 30-39 1552 1.49 1.31-1.56
N06AX16 Venlafaxine 30-39 3792 3.63 3.52-3.74
N06AX18 Reboxetin 30-39, 41 91 0.09 0.07-0.11
N06AX21 Duloxetine 30-39 1480 1.42 1.35-1.49
N06BA07 Modafinil 30-39 95 0.09 0.07-0.11
ATC codes (ATC), the corresponding chemical substances (Chem. Sub.) and ICD-10
ATC codes can be prescribed, number of older persons (n) prescribed each of ATC-
drugs for mental disorders, with 95% CI, during 2006, 2007 and 2008women both received equal amounts of prescriptions from
geriatricians and psychiatrists, men received prescriptions
from other specialists and physicians with no specialist
education to a higher extent than women.
Each year approximately 15% of the older population
received two or more substances for mental disorders on
one or recurrent occasions during the years 2006, 2007
and 2008 (see Table 5). The prescription of one chemicallation
2007 2008
n % 95% CI n % 95% CI
1082 1.01 0.95-1.07 1097 1.01 0.95-1.07
7877 7.38 7.23-7.54 7814 7.21 7.06-7.37
2308 2.16 2.08-2.25 2377 2.19 2.11-2.28
1436 1.35 1.28-1.42 1691 1.56 1.49-1.64
3982 3.73 3.62-2.85 5231 4.83 4.70-4.96
7807 7.32 7.16-7.48 9093 8.40 8.23-8.56
.46 19315 18.11 17.88-18.34 18477 17.06 16.84-17.28
.05 41725 39.12 38.82-39.41 41226 38.06 37.78-38.35
1119 1.05 0.99-1.11 1093 1.01 0.95-1.07
3910 3.67 3.55-3.78 3819 3.53 3.42-3.64
422 0.40 0.36-0.43 401 0.37 0.33-0.41
2827 2.65 2.55-2.75 2739 2.53 2.44-2.62
196 0.18 0.16-0.21 48 0.04 0.03-0.06
.60 11907 11.16 10.97-11.35 12275 11.33 11.14-11.52
367 0.34 0.31-0.38 307 0.28 0.25-0.32
342 0.32 0.29-0.35 322 0.30 0.26-0.33
167 0.16 0.13-0.18 152 0.14 0.12-0.16
37 0.03 0.02-0.05 28 0.03 0.02-0.04
1527 1.43 1.36-1.50 1523 1.41 1.34-1.48
10581 9.92 9.74-10.10 11500 10.62 10.43-10.80
1264 1.19 1.12-1.25 838 0.77 0.72-0.83
3848 3.61 3.50-3.72 4126 3.81 3.70-3.92
74 0.07 0.05-0.09 91 0.08 0.07-0.10
1602 1.50 1.43-1.57 2036 1.88 1.80-1.96
125 0.12 0.10-0.14 136 0.13 0.10-0.15
codes F20-42 (ICD) (Chapter V Mental and behavioral disorders) to which the





















































Figure 1 Percentage of physicians with specialist education in
geriatrics (GER), psychiatry (PSYCH), general practitioners (GP),
other specialists (OTH) or physicians without specialist
education (WO) prescribing drugs for mental disorders (Y-axis)
to older persons, in 5-year age brackets (X-axis). Data are
presented as average values for the 3-year period (2006 to 2008)
with SEM.
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increase in the prescription of two and three chemical
substances during the three years.
GPs prescribed drugs for mental disorders to both
women and men to a high extent during all three years
(see Figure 2). In 2006 the prescriptions written by geria-
tricians to women increased with increasing number of
substances, while their prescribing to men was consist-
ently low. The prescriptions written by psychiatrists to
both men and women increased with increasing number
of substances.
In 2007, both men and women were prescribed drugs
from geriatricians and from physicians with no specialist
education to a low extent. The prescriptions written by
psychiatrists to women increased with increasing number
of substances, while their prescribing to men decreased
with more than five substances. In the year 2008, prescrip-
tions by psychiatrists increased with increasing number of
substances for both men and women.Discussion
To our knowledge no other studies have evaluated the
prescription of drugs for older persons with mental dis-
orders other than dementia disorders, with a particular
focus on the medical specialty of the prescribing phys-
ician. This study shows that GPs represented the main
prescribers, whereas geriatricians and psychiatrists rarely
prescribed drugs to older persons.
The study includes all older persons (≥65) in Sweden
who received drugs dispensed at national pharmacies and
thus includes the vast majority of the older population.
The prevalence of prescriptions for drugs for mentaldisorders corresponds to approximately 7% of the older
population in Sweden [4]. In fact, each year, more than
half a million such prescriptions are dispensed to the older
population, and the most commonly prescribed drugs are
anxiolytics (benzodiazepines: oxazepam and diazepam)
and tricyclic antidepressants (amitriptyline). Although pre-
vious studies on potentially inappropriate drugs for older
persons suggested that benzodiazepines and tricyclic anti-
depressants are associated with a high risk of adverse
effects and should be replaced with safer alternative drugs
or therapies [30,31], the present study indicates that the
use of benzodiazepines and tricyclic antidepressants was
frequent. Approximately 60% of the older population was
prescribed benzodiazepines, and only a minor decrease
was observed over the course of the study. Furthermore,
antidepressants such as mirtazapine are shown to involve
high risk for adverse effects, including stroke or attempted
suicide [32], and despite its association with adverse
effects in older persons, prescriptions for mirtazapine
tended to increase over the years. These findings high-
light the clinical relevance of thoroughly and regularly
evaluating the continuous treatment of older persons.
Whereas approximately 85% of the older population
received only one chemical substance intended for treat-
ing mental disorders, approximately 15% received two or
more substances. Although this finding per se does not
indicate polypharmacy or risk for adverse drug reactions,
previous studies of the use of multiple drugs in older
persons suggested that it may result in inferior self-rated
health [33] and increased depressive symptoms [34].
The importance of expertise in geriatrics, gerontology
and psychiatry when treating older persons in general
and those with mental disorders in particular has been
debated [35-37]. Physicians without specialist education
prescribed all types of psychotropics, across all age
groups. As licensed physicians without specialist educa-
tion in Sweden have undergone at most two weeks of
training and education in geriatrics [14], their prescrib-
ing behavior may be detrimental to the quality and ad-
equacy of the treatment provided to older persons with
mental disorders. The present study does, however, con-
clude that the majority of prescriptions for drugs for
mental disorders were given by GPs, perhaps not sur-
prising as GPs represent the majority of physicians in
Sweden. GPs are recognized as an important part of psy-
chiatric care [38]. In the present study, the tendency of
GPs to prescribe drugs for mental disorders increased
with the age of the patient. This corresponds to a previ-
ous study showing that although GPs are aware of the
advantages of reducing the prescription of psychotropic
drugs, they struggle to convince their older patients of
the benefits of this [39].
A previous study has shown that licensed physicians,
other than psychiatrists, inaccurately diagnose mental
Table 4 The three most commonly prescribed drugs (classification, ATC-code level 5 and chemical substance) for
mental disorders (ICD-10) from 2006 to 2008: number (n) of and percentage (%), with 95% CI, of older persons (men
and women) prescribed drugs for mental disorders by specialists in geriatrics (GER), psychiatry (PSYCH), general
practitioners (GP), other specialists (OTH) or by physicians without specialist education (WO)
Classification ATC Chem. Sub. ICD-10 Specialists Patients’ sex 2006 2007 2008
n % 95% CI n % 95% CI n % 95% CI
Benzodiazepine
derivative
F20-39, 41 GER Men 470 4.0 3.6-4.3 492 4.1 3.7-4.4 551 4.6 4.2-4.9
Women 1218 4.1 3.9-4.3 1302 4.4 4.2-4.6 1378 4.7 4.5-5.0
N05BA04 PSYCH Men 394 3.3 3.0-3.7 405 3.4 3.0-3.7 413 3.4 3.1-3.8
Oxazepam Women 815 2.7 2.6-2.9 785 2.6 2.5-2.8 793 2.7 2.5-2.9
GP Men 8042 68.3 67.4-69.1 8285 68.6 67.7-69.4 8148 67.7 66.8-68.5
Women 22132 74.4 73.9-74.9 22099 74.6 74.1-75.0 21655 74.2 73.7-74.7
OTH Men 1613 13.7 13.1-14.3 1636 13.5 12.9-14.1 1677 13.9 13.3-14.5
Women 2929 9.8 9.5-10.2 2905 9.8 9.5-10.1 2816 9.6 9.3-10.0
WO Men 1591 13.5 12.9-14.1 1621 13.4 12.8-14.0 1618 13.4 12.8-14.0
Women 3462 11.6 11.3-12.0 3462 11.7 11.3-12.0 3419 11.7 11.3-12.1
Benzodiazepine
derivative
F20-39, 41 GER Men 262 3.5 3.1-3.9 233 3.2 2.8-3.6 247 3.6 3.2-4.0
Women 477 3.8 3.4-4.1 485 4.0 3.7-4.4 481 4.1 3.8-4.5
N05BA01 PSYCH Men 290 3.9 3.5-4.3 295 4.0 3.6-4.5 280 4.1 3.6-4.6
Diazepam Women 415 3.3 3.0-3.6 411 3.4 3.1-3.7 422 3.6 3.3-4.0
GP Men 4820 64.6 63.6-65.7 4799 65.8 64.7-66.9 4501 65.7 64.6-66.8
Women 9024 71.5 70.7-72.3 8577 71.4 70.6-72.2 8324 71.6 70.8-72.4
OTH Men 1374 18.4 17.5-19.3 1263 17.3 16.4-18.2 1145 16.7 15.8-17.6
Women 1727 13.7 13.1-14.3 1606 13.4 12.8-14.0 1510 13.0 12.4-13.6
WO Men 902 12.1 11.4-12.8 886 12.1 11.4-12.9 854 12.5 11.7-13.2
Women 1308 10.4 9.8-10.9 1280 10.7 10.1-11.2 1239 10.7 10.2-11.2
Non-selective monoamine
reuptake inhibitor
F20-39 GER Men 125 3.6 3.0-4.3 107 3.2 2.6-3.7 106 2.9 2.4-3.5
Women 269 3.2 2.8-3.5 280 3.3 2.9-3.7 276 3.2 2.8-3.6
PSYCH Men 101 2.9 2.4-3.5 95 2.8 2.2-3.4 97 2.7 2.2-3.2
N06AA09 Women 269 3.2 2.8-3.5 251 2.9 2.6-3.3 254 2.9 2.6-3.3
Amitriptyline GP Men 2133 62.1 60.5-63.8 2172 64.0 62.4-65.6 2276 63.1 61.5-64.7
Women 5868 69.2 68.2-70.2 5957 70.0 69.0-70.9 6082 70.2 69.2-71.1
OTH Men 585 17.0 15.8-18.3 553 16.3 15.1-17.5 624 17.3 16.1-18.5
Women 1038 12.2 11.5-12.9 1100 12.9 12.2-13.6 1133 13.1 12.4-13.8
WO Men 568 16.5 15.2-17.8 531 15.7 14.4-16.9 569 15.8 14.6-17.0
Women 1254 14.8 14.0-15.5 1143 13.4 12.7-14.1 1145 13.2 12.5-13.9
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inappropriate drugs [40]. Improved knowledge of geriat-
ric psychiatry, including alternative treatments for older
persons with mental disorders, would likely lead to the
decrease in inappropriate prescription of drugs. However,
although previous research has provided strong evidence
on how to improve the care of older persons with mental
disorders, translation into practice is rare [41,42]. Older
persons with mental disorders are consequently sub-
jected to lack of evidence-based care. To facilitate the
translation of research into practice and to meet the need
for specialists in geriatric psychiatry, it is essential to
launch new extended educational programs for geriatri-
cians and psychiatrists, as well as geriatric psychiatrists[43]. At present, only 60% trained geriatricians in Sweden
continue to work with older persons throughout their
careers [14]; low numbers of geriatricians indicates that
most older persons are treated by other specialists and
could explain the relatively low percentage of drugs pre-
scribed by geriatricians. The proportion of prescriptions
from geriatricians is overall low, but does increase up to
10% with increasing age of the patients; this may reflect
the tendency of older persons to be treated by geriatri-
cians as they approach 100 years of age. The proportion
of prescriptions written by psychiatrists is also remark-
ably low: only 5% of the older persons aged 65 to 69
received prescriptions from psychiatrists and this per-
centage decreased further with increasing age.
Table 5 Number (n) and percentage (%) of the older population age ≥65 in Sweden receiving prescriptions for one to
eight chemical substances for mental disorders, during the years 2006, 2007 and 2008
ATC 2006 2007 2008
Total Men Women Total Men Women Total Men Women
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
1 89046 (85.3) 31380 (86.5) 57666 (84.6) 90369 (84.7) 32314 (85.8) 58055 (84.1) 91368 (84.4) 32960 (85.6) 58407 (83.7)
2 13191 (12.6) 4175 (11.5) 9015 (13.2) 13871 (13.0) 4550 (12.1) 9320 (13.5) 14308 (13.2) 4695 (12.2) 9613 (13.8)
3 1848 (1.77) 599 (1.65) 1249 (1.83) 2037 (1.91) 662 (1.76) 1375 (1.99) 2160 (1.99) 688 (1.79) 1472 (2.11)
4 295 (0.28) 81 (0.22) 214 (0.31) 328 (0.31) 102 (0.27) 226 (0.33) 387 (0.36) 136 (0.35) 251 (0.36)
5 51 (0.05) 19 (0.05) 32 (0.05) 49 (0.05) 11 (0.03) 38 (0.06) 72 (0.07) 24 (0.06) 48 (0.07)
6 7 (0.01) 3 (0.01) 4 (0.01) 9 (0.01) 4 (0.01) 5 (0.01) 9 (0.01) 6 (0.02) 3 (0.00)
7 2 (0.00) 1 (0.00) 1 (0.00) 2 (0.00) 2 (0.00) 2 (0.00) 2 (0.01)
8 1 (0.00) 1 (0.00)
Total 104441 (100) 36259 (100) 68181 (100) 106665 (100) 37643 (100) 69021 (100) 108306 (100) 38511 (100) 69794 (100)
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http://www.biomedcentral.com/1471-244X/12/197The present study shows that women who are dis-
pensed several substances tend to receive their prescrip-
tions from geriatricians and psychiatrists to a higher
extent than men. It has been demonstrated that women
in old age are more likely to be affected by mental disor-
ders [44] and receive mental health care than men [45];
this may have increased the awareness of mental health
issues among older women and led to more frequent
referrals of women with mental disorders to specialists
such as geriatricians and psychiatrists. This supports the
necessity of continuing the discussion on gender differ-
ences in old age psychiatry and it becomes evident that
new and improved approaches in the care of older per-
sons are of utmost importance for providing the older
population with adequate care and treatment.
Given the complexity and challenges entailed in pro-
viding care for older persons, an increase in the number
of geriatric specialists with improved competence in
psychiatry or the involvement of teams of different spe-
cialists may positively contribute to improving the qual-
ity of care. Communication between GPs and other
specialists is vital for improving the care and treatment
of older persons in general [46] as well as older persons
with mental disorders [47,48]. In order to assist health-
care personnel in providing the highest quality care to
older persons with mental disorders, it is necessary to
provide appropriate and effective drug treatment.
Strengths and limitations
The SPDR includes all prescriptions dispensed at na-
tional pharmacies and consequently includes the vast
majority of the population in Sweden. The study popula-
tion therefore consisted of approximately 200 000 older
persons, which must be considered as a strength of this
study. Nonetheless, this study had some limitations.
Drugs that could be used for dementia disorders have
been excluded which may have led to some types ofselection bias. Due to the lack of diagnoses in the regis-
ter, drug use was used as a proxy for diagnoses. Conse-
quently, it is likely that some of the drugs that were
excluded due to plausible use for dementia disorders
may have been prescribed for an actual diagnosis and
treatment for a mental disorder and should have been
included in the study (diagnosis bias). The lack of diag-
noses is a crucial limitation that may have decreased the
validity of the results. To counteract this bias as far as
possible, the treatment guidelines and recommendations
set for each year of the study were thoroughly scruti-
nized and each disorder and ATC code was evaluated
with the help of practicing psychiatrists in order to
minimize inaccuracy. Drugs recommended as firsthand
options for treating dementia disorders or symptoms
during the years of the study were excluded to facilitate
studying mental disorders besides dementia disorders.
Consequently, this brought an unfortunate exclusion of
SSRIs and antipsychotics. In addition, with the register
lacking diagnoses the included drugs may have been pre-
scribed on indications other than mental disorders; tri-
cyclic antidepressants may be prescribed for e.g.
neuropathic pain rather than depression. However, as
this study aimed to present what medical specialties the
prescribers hold rather than the prevalence of certain
disorders, each disorder and connected drugs, including
all antidepressants and antipsychotics, will be further
analyzed in future studies.
With the character of the national register generaliza-
tions to older populations outside Sweden must be made
with consideration. One important limitation is that the
register does not include diagnoses. As a result of this
limitation the interpretation of the results with respect to
diagnoses and disorders may affect the outcome as the dif-
ferences in prescribing rates by different specialists could
be altered if diagnoses were to be included. However, the
register does deliver reliable information about the
Figure 2 Percentage of physicians with specialist education in geriatrics (GER), psychiatry (PSYCH), general practitioners (GP), other
specialists (OTH) or physicians without specialist education (WO) prescribing one or more ATC codes, level 5 (chemical substance) for
mental disorders to women (a, c, e) and men (b, d, f) during the years 2006, 2007 and 2008.
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http://www.biomedcentral.com/1471-244X/12/197competences of the prescribing physicians. Questions
regarding alternative therapies and non-pharmacological
treatment were not within the scope of this study. How-
ever, it would be of interest to study the frequency of pre-
scriptions for non-pharmacological treatments by the
various specialist categories. In addition, whether or not
the prescribing rates by different specialists differ depend-
ing on the characteristics of the drug remain unclear and
consequently future studies will include studying the pre-
scribing rates when including e.g. SSRIs in the analyses.
Possibly the prescribing differences between specialists
and physicians without specialist education depend on
specialists recurring more frequently to other classes of
drugs different from those used by physicians without spe-
cialist education. Hence future studies may answer ques-
tions as to whether or not psychiatrists and/or
geriatricians prescribe alternative treatments to a greater
extent than other specialists or, alternatively, if the degree
of patient contact with these specialists is overall low. In
future studies we will also examine subsamples of the
population and their prescriptions will be further scruti-
nized with respect to daily doses and comparisons to the
general recommendations in order to further elucidate the
subject.
Conclusions
The majority of prescriptions of drugs for mental disor-
ders were made by GPs and not by specialists on disor-
ders affecting the older population (geriatricians) or
specialists on mental disorders (psychiatrists). The most
commonly prescribed drugs were the benzodiazepines
oxazepam and diazepam, as well as the tricyclic anti-
depressant amitriptyline, despite the fact that clinical
guidelines do not recommend these medications for regu-
lar use in older persons. Approximately 15% of the older
population receiving drugs for mental disorders received
several substances. The results highlight the importance
of regularly evaluating pharmaceutical prescriptions to
older persons and raise questions about whether the in-
volvement of more geriatric or psychiatric specialists
would improve overall care.
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